Coreline Soft Co., Ltd.

Coreline Soft Co., Ltd. is a South Korean medical AI software developer specializing in diagnostic imaging analysis and clinical decision support. The company develops the AVIEW platform, a suite of AI-powered software solutions for detecting and analyzing pulmonary and neurological conditions from CT and other medical imaging modalities. Core product lines include AVIEW LCS Plus (lung nodule, emphysema, and coronary artery calcification detection), AVIEW LCS (lung nodule detection and characterization), AVIEW COPD (chronic obstructive pulmonary disease analysis), AVIEW CAC (coronary artery calcification scoring), AVIEW Lung Texture (pulmonary pattern analysis), AVIEW NeuroCAD (intracranial hemorrhage detection and diagnosis support), AVIEW ILA (interstitial lung abnormality analysis), AVIEW Modeler (3D medical image modeling and 3D printing), AVIEW RT ACS (organ auto-segmentation), and data management solutions including pseudonymization servers. The company serves healthcare facilities globally, with established partnerships in Europe, North America, and Asia-Pacific for lung cancer screening programs and clinical research. Solutions integrate with existing hospital PACS and clinical workflows to automate image interpretation and provide radiologists with quantitative diagnostic support. The company publishes peer-reviewed clinical research demonstrating product utility and has exceeded 500 clinical publications. Regulatory approvals and certifications are indicated by deployment in hospitals across multiple jurisdictions, though specific FDA 510(k) or CE mark designations are not explicitly stated in available content.